Sort
39,280 grants matching “leukemia”
Cancer and Leukemia Group B CCOP Research Base
$362,418Monica M Bertagnolli · Brigham And Women'S Hospital · U10 · FY2013 · CA
Defining the impact of clonal evolution on chronic lymphocytic leukemia
$362,378Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2018 · CA
Defining the impact of clonal evolution on chronic lymphocytic leukemia
$362,378Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Defining the impact of clonal evolution on chronic lymphocytic leukemia
$362,378Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2017 · CA
Defining the impact of clonal evolution on chronic lymphocytic leukemia
$362,378Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Defining the impact of clonal evolution on chronic lymphocytic leukemia
$362,378Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2014 · CA
New activities of the human DEK oncogene
$362,374Susanne Irmtraud Wells · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · CA
DNA REPAIR DEFECT IN FANCONI ANEMIA, GROUP A
$362,355Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2001 · HL
Population-Based Assessment of Cancer Trial Generalizability in the Elderly
$362,337Elizabeth B Lamont · Harvard Medical School · R01 · FY2012 · CA
Vector Production
$362,301Atsushi Miyanohara · Veterans Medical Research Fdn/San Diego · P01 · FY2015 · HL
Cell Competition in Myeloproliferative Neoplasms
$362,298Huichun Zhan · State University New York Stony Brook · R01 · FY2025 · CA
Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers
$362,294Catherine C Hedrick · La Jolla Institute For Immunology · U01 · FY2019 · CA
Ikaros-based epigenetic regulation of T cell leukemogenesis
$362,277Katia Georgopoulos · Massachusetts General Hospital · R01 · FY2013 · CA
Antileukemic effort of NK cells in HCT for pediatric AML
$362,276Wing Leung · St. Jude Children'S Research Hospital · R01 · FY2010 · CA
TYROSINE KINASE C-ABL AND BCR-ABL IN INTEGRIN DEPENDENT SIGNALING
$362,272Scripps Research Institute · P01 · FY2001 · HL
MLL POLYMORPHISMS IN TOPOISOMERASE LEUKEMOGENESIS
$362,272University Of Chicago · U01 · FY2002 · GM
MLL POLYMORPHISMS IN TOPOISOMERASE LEUKEMOGENESIS
$362,272University Of Chicago · U01 · FY2001 · GM
CYP3A4 GLUCURONIDATION OF EPIRUBICIN
$362,272University Of Chicago · U01 · FY2001 · GM
MLL POLYMORPHISMS IN TOPOISOMERASE LEUKEMOGENESIS
$362,272University Of Chicago · U01 · FY2000 · GM
CYP3A4 GLUCURONIDATION OF EPIRUBICIN
$362,272University Of Chicago · U01 · FY2000 · GM
CYP3A4 GLUCURONIDATION OF EPIRUBICIN
$362,272University Of Chicago · U01 · FY2002 · GM
CYP3A4 GLUCURONIDATION OF EPIRUBICIN
$362,272University Of Chicago · U01 · FY2002 · GM
MLL POLYMORPHISMS IN TOPOISOMERASE LEUKEMOGENESIS
$362,272University Of Chicago · U01 · FY2002 · GM
Prebiotics to Optimize the Microbiota and Improve Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation
$362,250Anthony Sung · Duke University · R01 · FY2022 · HL
Prebiotics to Optimize the Microbiota and Improve Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation
$362,250Anthony Sung · Duke University · R01 · FY2023 · HL